![Mark Quick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Quick
Director/Miembro de la Junta en
NANOLOGICA AB
.
Perfil
Mr. Mark R.
Quick is a Partner at Flerie Invest AB and a Member-Management Board & Partner at Flerie AB. He is on the Board of Directors at Nanologica AB, Recipharm HC Ltd., Aesica Formulation Development Ltd., Aesica Holdco Ltd., Binx Health Ltd., Recipharm Fontaine SAS, Recipharm Holdings Ltd., Recipharm Parets SL and Wasserburger Arzneimittelwerk GmbH.
Mr. Quick was previously employed as a Head-Corporate Development by Recipharm AB, a Head-Business Development by Celltech Manufacturing Services Ltd., an Account Manager by Medeva Pharma SA, a Demand Manager by Celltech Pharmaceuticals Ltd., and an Area Manager-Overseas Department by ICI Chemicals & Polymers Ltd. He also served on the board at Recipharm Ltd., Consort Medical Ltd. and Recipharm Monts SAS. He received his undergraduate degree from Nottingham Trent University and an MBA from The Open University Business School.
Cargos activos de Mark Quick
| Empresas | Cargo | Inicio |
|---|---|---|
| FLERIE INVEST AB | Corporate Officer/Principal | 01/01/2022 |
| NANOLOGICA AB | Director/Miembro de la Junta | 21/05/2026 |
Aesica Formulation Development Ltd.
 Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Director/Miembro de la Junta | 15/06/2020 |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Director/Miembro de la Junta | - |
NorthX Biologics AB
 NorthX Biologics AB BiotechnologyHealth Technology Engages in the development and manufacturing of biologics used in vaccines, gene therapy and other advanced applications | Director/Miembro de la Junta | - |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Inversor de Capital Privado | 01/03/2022 |
Recipharm HC Ltd.
 Recipharm HC Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Miembro de la Junta | 03/05/2018 |
Binx Health Ltd.
 Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development on biotechnology | Director/Miembro de la Junta | 25/02/2021 |
Aesica Holdco Ltd.
 Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company | Director/Miembro de la Junta | 04/02/2020 |
| ░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Antiguos cargos conocidos de Mark Quick.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formación de Mark Quick.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
64
Relaciones de 1er grado
24
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 24 |
|---|---|
Consort Medical Ltd.
 Consort Medical Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
ICI Chemicals & Polymers Ltd.
 ICI Chemicals & Polymers Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals and paints | Process Industries |
Nottingham Trent University
 Nottingham Trent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Recipharm AB
 Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
Medeva Pharma SA
 Medeva Pharma SA Medical DistributorsDistribution Services Business-to-business services for pharmacists | Distribution Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
Celltech Manufacturing Services Ltd.
 Celltech Manufacturing Services Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Recipharm Monts SAS
 Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Manufactures sterile injectable anesthetic products | Health Technology |
Aesica Formulation Development Ltd.
Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Recipharm Ltd.
 Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Wasserburger Arzneimittelwerk GmbH
 Wasserburger Arzneimittelwerk GmbH Pharmaceuticals: MajorHealth Technology Manufactures injectable pharmaceuticals | Health Technology |
Recipharm Parets SL
 Recipharm Parets SL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aesica Holdco Ltd.
Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company | Health Technology |
The Open University Business School
 The Open University Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Recipharm Fontaine SAS
 Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Finance |
UCB Pharma Ltd.
 UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nanologica AB
 Nanologica AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Health Technology |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Health Technology |
Binx Health Ltd.
Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development on biotechnology | Commercial Services |
Recipharm Holdings Ltd.
 Recipharm Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
AnaCardio AB
 AnaCardio AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops novel drugs to treat heart failure | Commercial Services |
Recipharm HC Ltd.
Recipharm HC Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
NorthX Biologics AB
NorthX Biologics AB BiotechnologyHealth Technology Engages in the development and manufacturing of biologics used in vaccines, gene therapy and other advanced applications | Health Technology |
- Bolsa de valores
- Insiders
- Mark Quick
